International Journal

1] [2017] MPTP-induced vulnerability of dopamine neurons in A53T α-synuclein overexpressed mice with the potential involvement of DJ-1 downregulation. Lee S, Oh ST, Jeong HJ, Pak SC, Park HJ, Kim J, Cho HS, Jeon S. Korean J Physiol Pharmacol. 2017 Nov;21(6):625-632. doi: 10.4196/kjpp.2017.21.6.625. Epub 2017 Oct 30. (IF: 2.06)
2] [2017] Electromagnetized gold nanoparticles mediated direct lineage reprogramming into induced dopamine neurons in vivo for Parkinson’s disease therapy. Yoo J, Lee E, Jung J, Kim J, Chang Y, Park G, Baek S, Jang W, Kwon Y, Kim S, Lengner C, Kim J, Nature Nanotechnology, (IF:33.4), 2017 Jul 17 (Corresponding)
3] [2017] Modeling Apolipoprotein E ε3/4 allele-associated sporadic Alzheimer’s disease in an induced neuron. Kim H, Yoo J, Shin J, Chang J, Jung J, Jo DG, Kim J, Jang W, Lengner CJ, Kim B, and Kim J, (Corresponding), Brain, (IF:10.2), 2017, (July, 3th)
4] [2017] Efficient direct lineage reprogramming of fibroblasts into induced cardiomyocytes using nanotopographical cues, Yoo J, Chang Y, Kim H, Park G, Park H, Baek S, Jeong G, Kim H, Kim B, Kim J, (Corresponding), Journal of Biomedical Nanotechnology, (IF:5.3), 2017, (13), 269-279
5] [2017] Inhibition of Drp1 Ameliorates Synaptic Depression, Aβ Deposition and Cognitive Impairment in Alzheimer's Disease Model. Baek SH, Park SJ, In Jeong J, Hyun Kim S, Han J, Won Kyung J, Baik SH, Choi Y, Choi BY, Park J, Bahn G, Shin JH, Sin Jo D, Lee JY, Jang CG, Arumugam TV, Kim J, Han JW, Koh JY, Cho DH, Jo DG. J Neurosci. 2017 Apr 21. pii: 2385-16
6] [2017] Effects of a combination treatment of KD5040 and L-dopa in a mouse model of Parkinson's disease. Ahn S, Song TJ, Park SU, Jeon S, Kim J, Oh JY, Jang J, Hong S, Song MA, Shin HS, Jung YR, Park HJ. BMC Complement Altern Med. 2017 Apr 19;17(1):220